Antimalarial medication multi-drug resistant "P. falciparum". It is a very potent blood schizonticide with a long half-life. It is thought to act by forming toxic heme complexes that damage parasitic food vacuoles. Mefloquine is effective in prophylaxis and for acute therapy. It is now used solely for the prevention of resistant strains of "P. falciparum" (usually combined with Artesunate) despite being effective against "P. vivax", "P. ovale" and "P. marlariae". Chloroquine/proguanil or sulfa drug-pyrimethamine combinations should be used in all other plasmodia infections. The major commercial manufacturer of mefloquine-based malaria treatment is Roche Pharmaceuticals, which markets the drug under the trade name
International Association for the Treatment of Sexual Offenders assessment and/or treatment of a child or juvenile who has committed a sexual offense: International Association for the Treatment of Sexual Offenders The International Association for the Treatment of Sexual Offenders (IATSO) is an international non-profit professional organization based in Vienna committed to the promotion of research of and treatment for sex offenders throughout the world. IATSO was founded in March 24, 1998 in Caracas, Venezuela during the 5th International Conference on the Treatment of Sex Offenders. They publish "Sex Offender Treatment", an international peer-reviewed journal open to all scientists and practitioners researching sexual abuse. In 2014 the first ever